Angiodynamics Inc (ANGO) — DEF 14A Filings
All DEF 14A filings from Angiodynamics Inc. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
AngioDynamics Shifts to Med Tech, Reports 8.1% Pro-Forma Growth
— Sep 25, 2025 Risk: medium
AngioDynamics, Inc. (ANGO) is holding its Annual Meeting of Shareholders on November 10, 2025, virtually, to vote on the election of two Class I directors, the -
ANGIOMEDICS INC Files DEF 14A for Executive Compensation
— Sep 26, 2024 Risk: low
ANGIOMEDICS INC filed a DEF 14A on September 26, 2024, detailing executive compensation and other corporate matters for the fiscal year ending May 31, 2024. The
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX